| Bid Price | 676.00p | High Price | 682.00p |
|---|
| Ask Price | 680.00p | Low Price | 630.00p |
|---|
| Open Price | 651.00p | Spread | 0.59% |
|---|
| Prev Close | 654.00p | Volume | 401,506 |
|---|
Oxford Biomedica PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 3, 2025 | 670.00 | 673.00 | 646.00 | 654.00 | 160,779 |
| Oct 31, 2025 | 659.00 | 670.00 | 650.00 | 657.00 | 153,238 |
| Oct 30, 2025 | 670.00 | 670.00 | 643.00 | 659.00 | 146,444 |
| Oct 29, 2025 | 641.00 | 663.00 | 623.00 | 654.00 | 232,510 |
Oxford Biomedica PLC Information
| Name | Oxford Biomedica PLC | Index | FTSE 250 |
|---|
| ISIN | GB00BDFBVT43 | Epic | OXB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | STMM |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 3,000 | Trading Status | Closed |
|---|
| Shares in Issue | 120.21 m | Prev Close | 654.00p |
|---|
| PE Ratio | 20.618557 | Market Cap | £819.80 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.25 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.144772 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 1.890585 | Quick Ratio | 1.444647 |
|---|
Oxford Biomedica PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 20/10/25 | BUY | Heather Preston | NED | 6,175 @ £5.93 | £36,633.00 |
| 22/08/25 | SELL | Dame Davies | NED | 4,563 @ £5.00 | £22,833.00 |
| 22/08/25 | BUY | Dame Davies | NED | 4,563 @ £4.36 | £19,895.00 |
| 15/08/25 | BUY | Roch Doliveux | CH | 67,000 @ £4.50 | £301,333.00 |
| 17/06/25 | BUY | Heather Preston | NED | 11,389 @ £3.24 | £36,900.00 |
| 16/11/23 | BUY | Michael Hayden | RES | 10,000 @ £1.93 | £19,281.00 |
| 14/11/23 | BUY | Michael Hayden | RES | 10,000 @ £1.93 | £19,281.00 |
| 11/10/23 | BUY | Namrata Patel | NED | 1,670 @ £2.99 | £4,993.00 |
| 27/09/23 | BUY | Michael Hayden | RES | 12,000 @ £2.94 | £35,220.00 |
| 26/09/23 | BUY | Leone Patterson | RES | 6,598 @ £2.91 | £19,167.00 |
Oxford Biomedica PLC News
